SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-002338
Filing Date
2018-08-08
Accepted
2018-08-08 16:21:39
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1821984.htm 10-Q 625994
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 12862
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 12938
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5168
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5190
  Complete submission text file 0001178913-18-002338.txt   2913879

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fomx-20180630.xml EX-101.INS 517548
7 XBRL TAXONOMY EXTENSION SCHEMA fomx-20180630.xsd EX-101.SCH 31045
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20180630_cal.xml EX-101.CAL 51483
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20180630_def.xml EX-101.DEF 90936
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20180630_lab.xml EX-101.LAB 248504
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20180630_pre.xml EX-101.PRE 176658
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36621 | Film No.: 181001658
SIC: 2833 Medicinal Chemicals & Botanical Products